Diagnostic evaluation of cancer antigens RAK .1. Cervical and ovarian cancer

Rakowicz-Szulczynska, Eva M.; Roszak, A.; Mackiewicz, A.; Markowska, Janina; McIntosh, David G.; Karczewska, Aldona; Godlewski, Dariusz; Snyder, William B.; Leary, D. R.; Smith, M. Charles

doi:10.3892/ijo.9.4.693

Cited by 6 publications

(18 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Activation by hormones, carcinogens, or opportunistic infections might lead to activation of the virus and relocation to specific organs. The latter hypothesis is strongly supported by the finding of RAK p160 (potential precursor of RAK p120 and p42) in the serum of cancer patients (25,29).…”

Section: Discussionmentioning

confidence: 81%

“…RAK antigens p120, p42, and p25 are expressed in cancers of the reproductive organs but are absent in normal tissues and in the majority of tissues adjacent to the cancer (21,22,24,26,28,29). Why cancers of different histological structures, which originated from completely different tissues, all express these unique proteins remained for a long time a medical and biological puzzle.…”

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 96%

“…The current study concentrated on gynecological cancer, which was found previously to contain HIV-1-like antigens (26,29). RAK antigens were found to be expressed by 95% of ovarian, uterine, and cervical cancer cases, and the HIV-1-like segments of uterine and ovarian cancer DNA exhibit over 90% homology to HIV-1.…”

mentioning

confidence: 99%

“…RAK markers p120, p42, and p25, which exhibit molecular weight correlation with the major proteins encoded by HIV-1, have been detected in 100% of breast cancer cases and in 100% of prostate cancer cases. The RAK antigen p160, which presumably represents a precursor of RAK p120 and p42, was also found in the serum of the majority of ovarian and cervical cancer patients (25,29).In addition to HIV-1-like antigens, DNA segments (142 bp) with 90 to 96% homology to the HIV-1 gene encoding the transmembrane protein gp41 have also been identified in breast (22,24) and prostate cancers (21). The DNA sequences with homology to HIV-1 have been deposited in the GenBank as the breast and prostate cancer-associated RAK alpha genes.…”

mentioning

confidence: 99%

See 4 more Smart Citations

Relevance of the Viral RAK Alpha Gene in Diagnosis of Malignant Versus Nonmalignant Tumors of the Ovary and Uterus

Rakowicz-Szulczynska

2000

Clin Diagn Lab Immunol

View full text Add to dashboard Cite

Human immunodeficiency virus type 1 (HIV-1)-like antigens RAK (named after the inventor E. M. Rakowicz) p120, p42, and p25, as well as HIV-1-like segments of cancer DNA (RAK gene alpha), have been found before in breast and prostate cancers. The present study focused on determining the value of markers RAK in the diagnosis and prognosis of gynecological cancer. Expression of RAK antigens in ovarian, uterine, cervical, and vulvar cancer, in benign tumors, in tissues adjacent to cancer, and in normal tissues was tested by Western blot hybridization of the electrophoretically separated proteins with monoclonal antibody RAK BrI. The RAK alpha gene was PCR amplified with HIV-1-derived primers SK68 and SK69. RAK antigens p120, p42, and p25 were found in 95% of ovarian, uterine, and cervical cancer cases and in 75% of vulvar cancer cases. The RAK alpha gene was expressed in 100% of cancer cases, in approximately 25% of benign ovarian tumors, and in 40% of benign tumors of the uterus. DNA sequences amplified in all cancer cases exhibited more than 90% homology to HIV-1 gp41 and were encoded for the functional peptide. DNA sequences found in benign tumors contained frameshift mutations and encoded truncated or nonfunctional peptides. Such sequences have not been amplified in normal tissues. RAK antigens and the RAK alpha gene seem to belong to a lentivirus type that is highly related to HIV-1. Beyond the diagnostic value of RAK markers, future cloning of the full viral genome would lead to a better understanding of the etiology of malignant and nonmalignant tumors of reproductive organs and to the development of novel therapeutic approaches.Cancers of the reproductive organs are the most common malignancies in women (7,13,19). Prognostic factors for those patients are directly dependent on the stage of the cancer at diagnosis. Earlier detection of breast, ovarian, cervical, or endometrial cancer would significantly increase survival rates of female patients (9,20,30). Only 10% of breast and 5% of ovarian cancer cases have a documented inherited pattern, associated mainly with the mutated genes BRCA (15,18,34) or the oncogene Her-2/Neu (31).Except for cervical cancer, which is predominantly associated with human papillomavirus (HPV) (2,8,14,17), a viral etiology of other types of female reproductive tract cancers remains unverified. However, the fact that the majority of papillomavirus-infected women do not develop cervical cancer strongly implies that HPV may be an important cofactor, but not the direct cause, of that cancer. Recent studies of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma (3) strongly suggest that the role of retroviruses in human cancer was somehow underestimated for a long time.Viral particles (4, 5, 6, 10, 11, 16) and DNA sequences (1, 32, 33) with homology to the mouse mammary tumor virus (MMTV) have been observed in breast cancer for some time. Since MMTV-like sequences are present in cancer patients, as well as in healthy patients, an involvement of this virus in the etiology o...

show abstract

Section: Discussionmentioning

confidence: 81%